ArticleTranslational oncology2022

The novel pretreatment immune prognostic index discriminates survival outcomes in locally advanced non-operative esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: a 6-year retrospective study.

Yilin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.